[Retrolective study design -- a new tool of evidence-based medicine].
Martin
S
S
Deutsche Diabetes Klinik, Deutsches Diabetes-Zentrum, DDZ, Leibniz-Zentrum für Diabetesforschung an der Heinrich-Heine-Universität Düsseldorf.
D001786:Blood Glucose / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring; D001835:Body Weight / Q000187:drug effects; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D019317:Evidence-Based Medicine / Q000379:methods*; D005905:Glyburide / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D019370:Observation / Q000379:methods; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D015203:Reproducibility of Results; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; C057619:glimepiride; D005905:Glyburide